 | • レポートコード：QAF27560 • 出版社/出版日：QYResearch / 2021年4月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の炭疽菌ワクチン市場について種類別（生ワクチン、無細胞PAワクチン）、用途別（人間、動物）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・炭疽菌ワクチン市場の概要 ・世界の主要地域別炭疽菌ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の炭疽菌ワクチン市場規模2016-2021：種類別（生ワクチン、無細胞PAワクチン） ・世界の炭疽菌ワクチン市場予測2012-2027：種類別（生ワクチン、無細胞PAワクチン） ・世界の炭疽菌ワクチン市場規模2016-2021：用途別（人間、動物） ・世界の炭疽菌ワクチン市場予測2012-2027：用途別（人間、動物） ・炭疽菌ワクチンのアメリカ市場規模と予測2016-2021 ・炭疽菌ワクチンのヨーロッパ市場規模と予測2016-2021 ・炭疽菌ワクチンの中国市場規模と予測2016-2021 ・炭疽菌ワクチンの日本市場規模と予測2016-2021 ・炭疽菌ワクチンの東南アジア市場規模と予測2016-2021 ・炭疽菌ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Emergent BioSolutions、Merial、Merck、Zoetis、Bayer Sanidad Animal、Colorado Serum、PharmAthene、Tiankang、Biogénesis-Bago、CAVAC、Rosenbusch、Agrovet、Vecol、CVCRI、IVPM、Prondil、CDV、Indian Immunologicals、Botswana Vaccine Institute、Ceva Santé Animale、Intervac、JOVAC） ・炭疽菌ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・炭疽菌ワクチンの市場動向・機会・課題 ・調査の結論 |
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
The classification of Anthrax Vaccines includes Live Vaccines and Cell free PA Vaccines, and the revenue proportion of Live Vaccines in 2016 is about 43%.
Anthrax Vaccines are widely used for human and animal. The most proportion of Anthrax Vaccines is used for animal, and the consumption proportion is about 95.1% in 2016.
South America region is the largest supplier of Anthrax Vaccines, with a production market share nearly 34.7% in 2016. Europe is the second largest supplier of Anthrax Vaccines, enjoying production market share nearly 17.6% in 2016.
South America is the largest sales place, with a sales market share nearly 39.3% in 2016. Following South America, Europe is the second largest sales place with the sales market share of 19.1%.
Market Analysis and Insights: Global Anthrax Vaccines Market
The global Anthrax Vaccines market was valued at US$ 683.2 in 2020 and will reach US$ 1060.3 million by the end of 2027, growing at a CAGR of 7.6% during 2022-2027.
Global Anthrax Vaccines Scope and Market Size
The global Anthrax Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anthrax Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Live Vaccines
Cell free PA Vaccines
Segment by Application
Human Use
Animal Use
The Anthrax Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Anthrax Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
1 Anthrax Vaccines Market Overview
1.1 Anthrax Vaccines Product Scope
1.2 Anthrax Vaccines Segment by Type
1.2.1 Global Anthrax Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Live Vaccines
1.2.3 Cell free PA Vaccines
1.3 Anthrax Vaccines Segment by Application
1.3.1 Global Anthrax Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Human Use
1.3.3 Animal Use
1.4 Anthrax Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Anthrax Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Anthrax Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Anthrax Vaccines Price Trends (2016-2027)
2 Anthrax Vaccines Estimates and Forecasts by Region
2.1 Global Anthrax Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Anthrax Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Anthrax Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Anthrax Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Anthrax Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Anthrax Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Anthrax Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Anthrax Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Anthrax Vaccines Estimates and Projections (2016-2027)
2.4.3 China Anthrax Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Anthrax Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Anthrax Vaccines Estimates and Projections (2016-2027)
2.4.6 India Anthrax Vaccines Estimates and Projections (2016-2027)
3 Global Anthrax Vaccines Competition Landscape by Players
3.1 Global Top Anthrax Vaccines Players by Sales (2016-2021)
3.2 Global Top Anthrax Vaccines Players by Revenue (2016-2021)
3.3 Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2020)
3.4 Global Anthrax Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Anthrax Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Anthrax Vaccines Market Size by Type
4.1 Global Anthrax Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Anthrax Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Anthrax Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Anthrax Vaccines Price by Type (2016-2021)
4.2 Global Anthrax Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Anthrax Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Anthrax Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Anthrax Vaccines Price Forecast by Type (2022-2027)
5 Global Anthrax Vaccines Market Size by Application
5.1 Global Anthrax Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Anthrax Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Anthrax Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Anthrax Vaccines Price by Application (2016-2021)
5.2 Global Anthrax Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Anthrax Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Anthrax Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Anthrax Vaccines Price Forecast by Application (2022-2027)
6 North America Anthrax Vaccines Market Facts & Figures
6.1 North America Anthrax Vaccines Sales by Company
6.1.1 North America Anthrax Vaccines Sales by Company (2016-2021)
6.1.2 North America Anthrax Vaccines Revenue by Company (2016-2021)
6.2 North America Anthrax Vaccines Sales Breakdown by Type
6.2.1 North America Anthrax Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Anthrax Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Anthrax Vaccines Sales Breakdown by Application
6.3.1 North America Anthrax Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Anthrax Vaccines Sales Breakdown by Application (2022-2027)
7 Europe Anthrax Vaccines Market Facts & Figures
7.1 Europe Anthrax Vaccines Sales by Company
7.1.1 Europe Anthrax Vaccines Sales by Company (2016-2021)
7.1.2 Europe Anthrax Vaccines Revenue by Company (2016-2021)
7.2 Europe Anthrax Vaccines Sales Breakdown by Type
7.2.1 Europe Anthrax Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Anthrax Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Anthrax Vaccines Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)
8 China Anthrax Vaccines Market Facts & Figures
8.1 China Anthrax Vaccines Sales by Company
8.1.1 China Anthrax Vaccines Sales by Company (2016-2021)
8.1.2 China Anthrax Vaccines Revenue by Company (2016-2021)
8.2 China Anthrax Vaccines Sales Breakdown by Type
8.2.1 China Anthrax Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Anthrax Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Anthrax Vaccines Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Anthrax Vaccines Market Facts & Figures
9.1 Japan Anthrax Vaccines Sales by Company
9.1.1 Japan Anthrax Vaccines Sales by Company (2016-2021)
9.1.2 Japan Anthrax Vaccines Revenue by Company (2016-2021)
9.2 Japan Anthrax Vaccines Sales Breakdown by Type
9.2.1 Japan Anthrax Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Anthrax Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Anthrax Vaccines Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Anthrax Vaccines Market Facts & Figures
10.1 Southeast Asia Anthrax Vaccines Sales by Company
10.1.1 Southeast Asia Anthrax Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Anthrax Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Anthrax Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Anthrax Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Anthrax Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Anthrax Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)
11 India Anthrax Vaccines Market Facts & Figures
11.1 India Anthrax Vaccines Sales by Company
11.1.1 India Anthrax Vaccines Sales by Company (2016-2021)
11.1.2 India Anthrax Vaccines Revenue by Company (2016-2021)
11.2 India Anthrax Vaccines Sales Breakdown by Type
11.2.1 India Anthrax Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Anthrax Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Anthrax Vaccines Sales Breakdown by Application
11.3.1 India Anthrax Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Anthrax Vaccines Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Anthrax Vaccines Business
12.1 Emergent BioSolutions
12.1.1 Emergent BioSolutions Corporation Information
12.1.2 Emergent BioSolutions Business Overview
12.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Emergent BioSolutions Anthrax Vaccines Products Offered
12.1.5 Emergent BioSolutions Recent Development
12.2 Merial
12.2.1 Merial Corporation Information
12.2.2 Merial Business Overview
12.2.3 Merial Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merial Anthrax Vaccines Products Offered
12.2.5 Merial Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Anthrax Vaccines Products Offered
12.3.5 Merck Recent Development
12.4 Zoetis
12.4.1 Zoetis Corporation Information
12.4.2 Zoetis Business Overview
12.4.3 Zoetis Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Zoetis Anthrax Vaccines Products Offered
12.4.5 Zoetis Recent Development
12.5 Bayer Sanidad Animal
12.5.1 Bayer Sanidad Animal Corporation Information
12.5.2 Bayer Sanidad Animal Business Overview
12.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer Sanidad Animal Anthrax Vaccines Products Offered
12.5.5 Bayer Sanidad Animal Recent Development
12.6 Colorado Serum
12.6.1 Colorado Serum Corporation Information
12.6.2 Colorado Serum Business Overview
12.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Colorado Serum Anthrax Vaccines Products Offered
12.6.5 Colorado Serum Recent Development
12.7 PharmAthene
12.7.1 PharmAthene Corporation Information
12.7.2 PharmAthene Business Overview
12.7.3 PharmAthene Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 PharmAthene Anthrax Vaccines Products Offered
12.7.5 PharmAthene Recent Development
12.8 Tiankang
12.8.1 Tiankang Corporation Information
12.8.2 Tiankang Business Overview
12.8.3 Tiankang Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Tiankang Anthrax Vaccines Products Offered
12.8.5 Tiankang Recent Development
12.9 Biogénesis-Bago
12.9.1 Biogénesis-Bago Corporation Information
12.9.2 Biogénesis-Bago Business Overview
12.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Biogénesis-Bago Anthrax Vaccines Products Offered
12.9.5 Biogénesis-Bago Recent Development
12.10 CAVAC
12.10.1 CAVAC Corporation Information
12.10.2 CAVAC Business Overview
12.10.3 CAVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CAVAC Anthrax Vaccines Products Offered
12.10.5 CAVAC Recent Development
12.11 Rosenbusch
12.11.1 Rosenbusch Corporation Information
12.11.2 Rosenbusch Business Overview
12.11.3 Rosenbusch Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Rosenbusch Anthrax Vaccines Products Offered
12.11.5 Rosenbusch Recent Development
12.12 Agrovet
12.12.1 Agrovet Corporation Information
12.12.2 Agrovet Business Overview
12.12.3 Agrovet Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Agrovet Anthrax Vaccines Products Offered
12.12.5 Agrovet Recent Development
12.13 Vecol
12.13.1 Vecol Corporation Information
12.13.2 Vecol Business Overview
12.13.3 Vecol Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Vecol Anthrax Vaccines Products Offered
12.13.5 Vecol Recent Development
12.14 CVCRI
12.14.1 CVCRI Corporation Information
12.14.2 CVCRI Business Overview
12.14.3 CVCRI Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 CVCRI Anthrax Vaccines Products Offered
12.14.5 CVCRI Recent Development
12.15 IVPM
12.15.1 IVPM Corporation Information
12.15.2 IVPM Business Overview
12.15.3 IVPM Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 IVPM Anthrax Vaccines Products Offered
12.15.5 IVPM Recent Development
12.16 Prondil
12.16.1 Prondil Corporation Information
12.16.2 Prondil Business Overview
12.16.3 Prondil Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Prondil Anthrax Vaccines Products Offered
12.16.5 Prondil Recent Development
12.17 CDV
12.17.1 CDV Corporation Information
12.17.2 CDV Business Overview
12.17.3 CDV Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.17.4 CDV Anthrax Vaccines Products Offered
12.17.5 CDV Recent Development
12.18 Indian Immunologicals
12.18.1 Indian Immunologicals Corporation Information
12.18.2 Indian Immunologicals Business Overview
12.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Indian Immunologicals Anthrax Vaccines Products Offered
12.18.5 Indian Immunologicals Recent Development
12.19 Botswana Vaccine Institute
12.19.1 Botswana Vaccine Institute Corporation Information
12.19.2 Botswana Vaccine Institute Business Overview
12.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Botswana Vaccine Institute Anthrax Vaccines Products Offered
12.19.5 Botswana Vaccine Institute Recent Development
12.20 Ceva Santé Animale
12.20.1 Ceva Santé Animale Corporation Information
12.20.2 Ceva Santé Animale Business Overview
12.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Ceva Santé Animale Anthrax Vaccines Products Offered
12.20.5 Ceva Santé Animale Recent Development
12.21 Intervac
12.21.1 Intervac Corporation Information
12.21.2 Intervac Business Overview
12.21.3 Intervac Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Intervac Anthrax Vaccines Products Offered
12.21.5 Intervac Recent Development
12.22 JOVAC
12.22.1 JOVAC Corporation Information
12.22.2 JOVAC Business Overview
12.22.3 JOVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.22.4 JOVAC Anthrax Vaccines Products Offered
12.22.5 JOVAC Recent Development
13 Anthrax Vaccines Manufacturing Cost Analysis
13.1 Anthrax Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anthrax Vaccines
13.4 Anthrax Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anthrax Vaccines Distributors List
14.3 Anthrax Vaccines Customers
15 Market Dynamics
15.1 Anthrax Vaccines Market Trends
15.2 Anthrax Vaccines Drivers
15.3 Anthrax Vaccines Market Challenges
15.4 Anthrax Vaccines Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anthrax Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Anthrax Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Anthrax Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Anthrax Vaccines Sales (M Doses) by Region (2016-2021)
Table 5. Global Anthrax Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Anthrax Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Anthrax Vaccines Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Anthrax Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Anthrax Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Anthrax Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Anthrax Vaccines Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Anthrax Vaccines Sales Share by Company (2016-2021)
Table 14. Global Anthrax Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Anthrax Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Anthrax Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anthrax Vaccines as of 2020)
Table 17. Global Anthrax Vaccines Average Price (USD/K Doses) of Key Company (2016-2021)
Table 18. Manufacturers Anthrax Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Anthrax Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Anthrax Vaccines Sales (M Doses) by Type (2016-2021)
Table 22. Global Anthrax Vaccines Sales Share by Type (2016-2021)
Table 23. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Anthrax Vaccines Price (USD/K Doses) by Type (2016-2021)
Table 25. Global Anthrax Vaccines Sales Share by Type (2022-2027)
Table 26. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Anthrax Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Anthrax Vaccines Price (USD/K Doses) by Type (2022-2027)
Table 29. Global Anthrax Vaccines Sales (M Doses) by Application (2016-2021)
Table 30. Global Anthrax Vaccines Sales Share by Application (2016-2021)
Table 31. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Anthrax Vaccines Price (USD/K Doses) by Application (2016-2021)
Table 33. Global Anthrax Vaccines Sales (M Doses) by Application (2022-2027)
Table 34. Global Anthrax Vaccines Sales Share by Application (2022-2027)
Table 35. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Anthrax Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Anthrax Vaccines Price (USD/K Doses) by Application (2022-2027)
Table 38. North America Anthrax Vaccines Sales (M Doses) by Company (2016-2021)
Table 39. North America Anthrax Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Anthrax Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Anthrax Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Anthrax Vaccines Sales by Type (2016-2021) & (M Doses)
Table 43. North America Anthrax Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Anthrax Vaccines Sales by Type (2022-2027) & (M Doses)
Table 45. North America Anthrax Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Anthrax Vaccines Sales by Application (2016-2021) & (M Doses)
Table 47. North America Anthrax Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Anthrax Vaccines Sales by Application (2022-2027) & (M Doses)
Table 49. North America Anthrax Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Anthrax Vaccines Sales (M Doses) by Company (2016-2021)
Table 51. Europe Anthrax Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Anthrax Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Anthrax Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Anthrax Vaccines Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Anthrax Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Anthrax Vaccines Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Anthrax Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Anthrax Vaccines Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Anthrax Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Anthrax Vaccines Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Anthrax Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Anthrax Vaccines Sales (M Doses) by Company (2016-2021)
Table 63. China Anthrax Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Anthrax Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Anthrax Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Anthrax Vaccines Sales by Type (2016-2021) & (M Doses)
Table 67. China Anthrax Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Anthrax Vaccines Sales by Type (2022-2027) & (M Doses)
Table 69. China Anthrax Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Anthrax Vaccines Sales by Application (2016-2021) & (M Doses)
Table 71. China Anthrax Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Anthrax Vaccines Sales by Application (2022-2027) & (M Doses)
Table 73. China Anthrax Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Anthrax Vaccines Sales (M Doses) by Company (2016-2021)
Table 75. Japan Anthrax Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Anthrax Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Anthrax Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Anthrax Vaccines Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Anthrax Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Anthrax Vaccines Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Anthrax Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Anthrax Vaccines Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Anthrax Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Anthrax Vaccines Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Anthrax Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Anthrax Vaccines Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Anthrax Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Anthrax Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Anthrax Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Anthrax Vaccines Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Anthrax Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Anthrax Vaccines Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Anthrax Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Anthrax Vaccines Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Anthrax Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Anthrax Vaccines Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Anthrax Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Anthrax Vaccines Sales (M Doses) by Company (2016-2021)
Table 99. India Anthrax Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Anthrax Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Anthrax Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Anthrax Vaccines Sales by Type (2016-2021) & (M Doses)
Table 103. India Anthrax Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Anthrax Vaccines Sales by Type (2022-2027) & (M Doses)
Table 105. India Anthrax Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Anthrax Vaccines Sales by Application (2016-2021) & (M Doses)
Table 107. India Anthrax Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Anthrax Vaccines Sales by Application (2022-2027) & (M Doses)
Table 109. India Anthrax Vaccines Sales Market Share by Application (2022-2027)
Table 110. Emergent BioSolutions Corporation Information
Table 111. Emergent BioSolutions Description and Business Overview
Table 112. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 113. Emergent BioSolutions Anthrax Vaccines Product
Table 114. Emergent BioSolutions Recent Development
Table 115. Merial Corporation Information
Table 116. Merial Description and Business Overview
Table 117. Merial Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 118. Merial Anthrax Vaccines Product
Table 119. Merial Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 123. Merck Anthrax Vaccines Product
Table 124. Merck Recent Development
Table 125. Zoetis Corporation Information
Table 126. Zoetis Description and Business Overview
Table 127. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 128. Zoetis Anthrax Vaccines Product
Table 129. Zoetis Recent Development
Table 130. Bayer Sanidad Animal Corporation Information
Table 131. Bayer Sanidad Animal Description and Business Overview
Table 132. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 133. Bayer Sanidad Animal Anthrax Vaccines Product
Table 134. Bayer Sanidad Animal Recent Development
Table 135. Colorado Serum Corporation Information
Table 136. Colorado Serum Description and Business Overview
Table 137. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 138. Colorado Serum Anthrax Vaccines Product
Table 139. Colorado Serum Recent Development
Table 140. PharmAthene Corporation Information
Table 141. PharmAthene Description and Business Overview
Table 142. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 143. PharmAthene Anthrax Vaccines Product
Table 144. PharmAthene Recent Development
Table 145. Tiankang Corporation Information
Table 146. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 147. Tiankang Description and Business Overview
Table 148. Tiankang Anthrax Vaccines Product
Table 149. Tiankang Recent Development
Table 150. Biogénesis-Bago Corporation Information
Table 151. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 152. Biogénesis-Bago Description and Business Overview
Table 153. Biogénesis-Bago Anthrax Vaccines Product
Table 154. Biogénesis-Bago Recent Development
Table 155. CAVAC Corporation Information
Table 156. CAVAC Description and Business Overview
Table 157. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 158. CAVAC Anthrax Vaccines Product
Table 159. CAVAC Recent Development
Table 160. Rosenbusch Corporation Information
Table 161. Rosenbusch Description and Business Overview
Table 162. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 163. Rosenbusch Anthrax Vaccines Product
Table 164. Rosenbusch Recent Development
Table 165. Agrovet Corporation Information
Table 166. Agrovet Description and Business Overview
Table 167. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 168. Agrovet Anthrax Vaccines Product
Table 169. Agrovet Recent Development
Table 170. Vecol Corporation Information
Table 171. Vecol Description and Business Overview
Table 172. Vecol Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 173. Vecol Anthrax Vaccines Product
Table 174. Vecol Recent Development
Table 175. CVCRI Corporation Information
Table 176. CVCRI Description and Business Overview
Table 177. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 178. CVCRI Anthrax Vaccines Product
Table 179. CVCRI Recent Development
Table 180. IVPM Corporation Information
Table 181. IVPM Description and Business Overview
Table 182. IVPM Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 183. IVPM Anthrax Vaccines Product
Table 184. IVPM Recent Development
Table 185. Prondil Corporation Information
Table 186. Prondil Description and Business Overview
Table 187. Prondil Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 188. Prondil Anthrax Vaccines Product
Table 189. Prondil Recent Development
Table 190. CDV Corporation Information
Table 191. CDV Description and Business Overview
Table 192. CDV Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 193. CDV Anthrax Vaccines Product
Table 194. CDV Recent Development
Table 195. Indian Immunologicals Corporation Information
Table 196. Indian Immunologicals Description and Business Overview
Table 197. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 198. Indian Immunologicals Anthrax Vaccines Product
Table 199. Indian Immunologicals Recent Development
Table 200. Botswana Vaccine Institute Corporation Information
Table 201. Botswana Vaccine Institute Description and Business Overview
Table 202. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 203. Botswana Vaccine Institute Anthrax Vaccines Product
Table 204. Botswana Vaccine Institute Recent Development
Table 205. Ceva Santé Animale Corporation Information
Table 206. Ceva Santé Animale Description and Business Overview
Table 207. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 208. Ceva Santé Animale Anthrax Vaccines Product
Table 209. Ceva Santé Animale Recent Development
Table 210. Intervac Corporation Information
Table 211. Intervac Description and Business Overview
Table 212. Intervac Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 213. Intervac Anthrax Vaccines Product
Table 214. Intervac Recent Development
Table 215. JOVAC Corporation Information
Table 216. JOVAC Description and Business Overview
Table 217. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 218. JOVAC Anthrax Vaccines Product
Table 219. JOVAC Recent Development
Table 220. Production Base and Market Concentration Rate of Raw Material
Table 221. Key Suppliers of Raw Materials
Table 222. Anthrax Vaccines Distributors List
Table 223. Anthrax Vaccines Customers List
Table 224. Anthrax Vaccines Market Trends
Table 225. Anthrax Vaccines Market Drivers
Table 226. Anthrax Vaccines Market Challenges
Table 227. Anthrax Vaccines Market Restraints
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
List of Figures
Figure 1. Anthrax Vaccines Product Picture
Figure 2. Global Anthrax Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anthrax Vaccines Sales Market Share by Application in 2021 & 2027
Figure 6. Human Use Examples
Figure 7. Animal Use Examples
Figure 8. Global Anthrax Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Anthrax Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Anthrax Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 11. Global Anthrax Vaccines Price Trends Growth Rate (2016-2027) (USD/K Doses)
Figure 12. Global Anthrax Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Anthrax Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Anthrax Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Anthrax Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 16. Europe Anthrax Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Anthrax Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Anthrax Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Anthrax Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Anthrax Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Anthrax Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Anthrax Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Anthrax Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Anthrax Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Anthrax Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Anthrax Vaccines Players Market Share by Revenue in Anthrax Vaccines: 2016 & 2020
Figure 27. Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Anthrax Vaccines Revenue Share by Type (2016-2021)
Figure 29. Global Anthrax Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Anthrax Vaccines Revenue Share by Application (2016-2021)
Figure 31. Global Anthrax Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Anthrax Vaccines Sales Market Share by Type in 2020
Figure 33. North America Anthrax Vaccines Sales Market Share by Application in 2020
Figure 34. Europe Anthrax Vaccines Sales Market Share by Type in 2020
Figure 35. Europe Anthrax Vaccines Sales Market Share by Application in 2020
Figure 36. China Anthrax Vaccines Sales Market Share by Type in 2020
Figure 37. China Anthrax Vaccines Sales Market Share by Application in 2020
Figure 38. Japan Anthrax Vaccines Sales Market Share by Type in 2020
Figure 39. Japan Anthrax Vaccines Sales Market Share by Application in 2020
Figure 40. Southeast Asia Anthrax Vaccines Sales Market Share by Type in 2020
Figure 41. Southeast Asia Anthrax Vaccines Sales Market Share by Application in 2020
Figure 42. India Anthrax Vaccines Sales Market Share by Type in 2020
Figure 43. India Anthrax Vaccines Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Anthrax Vaccines
Figure 46. Manufacturing Process Analysis of Anthrax Vaccines
Figure 47. Anthrax Vaccines Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界のヒトDNAワクチン市場規模・現状・予測（2021年-2027年） DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…- 世界の牛用ワクチン市場規模・現状・予測（2021年-2027年） One of the most common questions in cow/calf production is what vaccines are necessary on an annual basis to keep the herd healthy. Market Analysis and Insights: Global Cattle Vaccines Market The global Cattle Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in …
- DNAワクチンのグローバル市場2021 The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines. N…
- 世界の豚流行性下痢ワクチン市場規模・現状・予測（2021年-2027年） Swine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease. Market Analysis and Insights: Global Swine Epidemic Diarrhea Vaccines Market The global Swine Epidemic Diarrhea Vaccines market size is projected to …
- 世界の牛用呼吸器ワクチン市場規模・現状・予測（2021年-2027年） Bovine respiratory vaccines for the prevention of respiratory diseases in cattle such as Infectious Bovine Rhinotracheitis (IBR), Bovine Viral Diarrhea (BVD), Parainfluenza 3 (PI3) and Bovine Respiratory Syncytial Virus (BRSV). A variety of vaccines are available. See product details for vaccine use…